COVID-19’s lasting mark: Long-term smell and taste loss

FHS
March 1, 2024
4:04 am

Study reveals prolonged olfactory and gustatory dysfunction in some COVID-19 recoverees, highlighting a need for better clinical support and understanding of long-term effects.

Breakthrough research on glioma progression wins BIAL Award in Biomedicine

A team of researchers from Germany, the USA, the UK, and Norway won the third edition of the BIAL Award in Biomedicine, a 300,000 Euro

February 21, 2024

Radiopharmaceutical biotech Radionetics in fundraising mode with $54.2M so far

Radionetics Oncology is in the midst of a fundraising drive worth $68.7 million, with the California-based company having raised $54.2 million so far, per an

August 17, 2023

Updated: Novartis close to acquiring Cytokinetics after biotech’s PhIII heart disease win — WSJ

Novartis is in discussions to buy Cytokinetics, the Wall Street Journal reported Monday, sending the biotech’s stock $CYTK soaring nearly 15%. The deal could be

January 9, 2024

Supercharge Your Portfolio with Future Health Stocks!

Join us for Profitable Insights & Expert Tips!

With expert analysis, comprehensive market coverage, and actionable insights, our newsletter equips you with the knowledge & tools necessary to make informed decisions & maximize your potential returns in the dynamic world of future health stocks.